Skip to main content
. 2017 Mar 8;8(22):35558–35572. doi: 10.18632/oncotarget.16009

Figure 3. Effects of COX2 over-expression or RNAi on the changes of depressive-like behaviors in CUMS-treated rats.

Figure 3

a. Effects of COX2 over-expressing lentivirus, LV-si-COX2 or LV-Mock (15 ul, 10 8 TU/ml, intracerebroventricular injection, respectively) on the changes of body weight in CUMS-treated rats. b. Effects of COX2 over-expressing lentivirus, LV-si-COX2 or LV-Mock (15 ul, 10 8 TU/ml, intracerebroventricular injection, respectively) on the changes of sucrose preference test in CUMS-treated rats. Each value represents the mean ± SD using a one-way ANOVA with a Bonferroni correction. **P < 0.01 vs control group. # and ## P < 0.05 and < 0.01 vs the CUMS group. n = 10.

HHS Vulnerability Disclosure